Rosen Quoted on Prescription Drug Industry

19 March 2015 Washington Post News

Washington Post

Partner David Rosen was quoted in a Washington Post article, “Regulators Take a Growing Interest in Drugmakers’ Moves to Protect Profits,” on March 19, 2015. The article discussed the competitive nature of patents for the prescription drug market, along with related antitrust issues. Rosen was quoted saying, “This industry is under a lot of scrutiny because the cost savings in the generic world are pretty high for the public.”

Insights

ERISA/Cybersecurity Considerations in the COVID Age
21 October 2020
Privacy, Cybersecurity & Technology Law Perspectives
A Review of Recent Whistleblower Developments
21 October 2020
Legal News: Whistleblower Developments
U.S. EPA Formalizes Reversal of “Once In/Always In” Emission Permitting Policy
21 October 2020
Legal News: Environmental
Georgia Finalizes New Telemedicine Practice Rules
21 October 2020
Health Care Law Today
Discover Telehealth Conference
18 November 2020
Webinar
ACI’s Proficiency Series on Rx Drug Pricing and Rebate Fundamentals
17-19 November 2020
Webinar
2020 NDI Reimagined
11-13 November 2020
Webinar
Foley’s Annual Government Contracts Update
10 November 2020